ArticleSAGE open medical case reports2025
Massive pleural effusion as a delayed complication of pulmonary embolism in an adolescent patient with factor V Leiden mutation and obesity: A case report.
Article in SAGE open medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary embolism in the pediatric population is rare but could be a cause of significant morbidity and mortality. Pleural effusion often complicates pulmonary embolism but it is usually small to moderate in size. We report the case of a 16-year-old male patient with massive pleural effusion as a delayed complication of pulmonary embolism. He presented with pleuritic chest pain, dyspnea, and deep venous thrombosis in the leg, the risk factors for which were obesity and a hypercoagulable state due to a factor V Leiden heterozygous mutation. The patient received anticoagulation treatment with enoxaparin. Three weeks after discharge home, he was readmitted for new-onset chest pain and dyspnea. He was found to have massive left pleural effusion without recurrent pulmonary embolism. The effusion was drained because it compromised the patient's respiratory function. The mechanism for pleural effusion in pulmonary embolism is unclear but may involve increased pulmonary capillary permeability due to inflammatory mediators released from platelet-rich thrombi and pulmonary ischemia distal to the vascular obstruction. This case highlights the potential for late pleural effusion progression in pediatric pulmonary embolism and the need to manage large effusions to prevent respiratory compromise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.